The pathophysiological function of non-gastrointestinal farnesoid X receptor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pathophysiological function of non-gastrointestinal farnesoid X receptor
Authors
Keywords
farnesoid X receptor, hepatocytes, immune cells, central nervous system, cardiovascular system, nonalcoholic fatty liver disease, kidney
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 226, Issue -, Pages 107867
Publisher
Elsevier BV
Online
2021-04-23
DOI
10.1016/j.pharmthera.2021.107867
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic fatty liver disease: another leap forward
- (2021) Manal F. Abdelmalek Nature Reviews Gastroenterology & Hepatology
- Farnesoid X receptor promotes renal ischaemia‐reperfusion injury by inducing tubular epithelial cell apoptosis
- (2021) Yao Xu et al. CELL PROLIFERATION
- The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
- (2021) Lulu Sun et al. Nature Reviews Gastroenterology & Hepatology
- FXR-Deoxycholic Acid-TNFα Axis Modulates Acetaminophen-Induced Hepatotoxicity
- (2021) Tingting Yan et al. TOXICOLOGICAL SCIENCES
- Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism
- (2020) Wen‐Jun Jia et al. FEBS Journal
- Bile Acid Sequestration Reverses Liver Injury and Prevents Progression of NASH in Western Diet-Fed Mice
- (2020) Shogo Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
- (2020) Jiyu Zhou et al. Nature Communications
- FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity
- (2020) Kun Wu et al. Cell Communication and Signaling
- Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver
- (2020) Bing Wang et al. EXPERIMENTAL CELL RESEARCH
- Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
- (2020) Pavan Bhargava et al. JOURNAL OF CLINICAL INVESTIGATION
- Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice
- (2020) Hui-Min Shan et al. Journal of Neuroinflammation
- Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
- (2020) Clarissa Campbell et al. NATURE
- Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders
- (2020) Stefano Fiorucci et al. CURRENT OPINION IN PHARMACOLOGY
- FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs
- (2020) Jose Miguel Ramos Pittol et al. GASTROENTEROLOGY
- Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
- (2020) Snehal N. Chaudhari et al. Nature Chemical Biology
- Bile Acid Supplementation Improves Murine Pancreatitis in Association With the Gut Microbiota
- (2020) You-Dong Wan et al. Frontiers in Physiology
- The Status of Bile Acids and Farnesoid X Receptor in Brain and Liver of Rats with Thioacetamide-Induced Acute Liver Failure
- (2020) Anna Maria Czarnecka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder
- (2020) Lei Fan et al. JOURNAL OF HEPATOLOGY
- Regulation of Lung Macrophage Activation and Oxidative Stress Following Ozone Exposure by Farnesoid X Receptor
- (2020) Mary Francis et al. TOXICOLOGICAL SCIENCES
- The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal FXR Signaling Pathway and Inhibition of Hepatic Gluconeogenesis
- (2020) Runbin Sun et al. DRUG METABOLISM AND DISPOSITION
- Betulinic acid alleviates endoplasmic reticulum stress-mediated NAFLD through activation of FXR in mice
- (2019) Ming Gu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis
- (2019) Sangwon Byun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
- (2019) Rie Ouchi et al. Cell Metabolism
- Direct and Indirect Effects of FGF15 and FGF19 on Liver Fibrosis Development
- (2019) J D Schumacher et al. HEPATOLOGY
- Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis
- (2019) Fabian Glaser et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities
- (2019) Aliya F. Gulamhusein et al. Nature Reviews Gastroenterology & Hepatology
- Farnesoid X Receptor (FXR) Aggravates Amyloid-β-Triggered Apoptosis by Modulating the cAMP-Response Element-Binding Protein (CREB)/Brain-Derived Neurotrophic Factor (BDNF) Pathway In Vitro
- (2019) Qingfa Chen et al. MEDICAL SCIENCE MONITOR
- Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo
- (2018) Lingli Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Glucagon-receptor Signaling Regulates Energy Metabolism Via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21
- (2018) Teayoun Kim et al. DIABETES
- FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice
- (2018) Min Zhang et al. DIGESTIVE AND LIVER DISEASE
- Bile acids and FXR in functional gastrointestinal disorders
- (2018) Paula Mosińska et al. DIGESTIVE AND LIVER DISEASE
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice
- (2018) Xiaoying Liu et al. HEPATOLOGY
- The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7
- (2018) Xiang Jiang et al. JOURNAL OF AUTOIMMUNITY
- The Nuclear Bile Acid Receptor FXR is a PKA- and FOXA2-Sensitive Activator of Fasting Hepatic Gluconeogenesis
- (2018) Maheul Ploton et al. JOURNAL OF HEPATOLOGY
- HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter
- (2018) Xin Xu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress
- (2018) Sujuan Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hippocampal FXR plays a role in the pathogenesis of depression: A preliminary study based on lentiviral gene modulation
- (2018) Wei-Guan Chen et al. PSYCHIATRY RESEARCH
- Macrophage-Targeted Therapeutics for Metabolic Disease
- (2018) Kristin R. Peterson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
- (2018) Sangwon Byun et al. Nature Communications
- Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
- (2018) Toshihiro Goto et al. Scientific Reports
- FXR modulators for enterohepatic and metabolic diseases
- (2018) Hong Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury
- (2018) Chang Yeob Han et al. Cell Reports
- Bile Acids Activated Receptors Regulate Innate Immunity
- (2018) Stefano Fiorucci et al. Frontiers in Immunology
- Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
- (2018) Siamak MahmoudianDehkordi et al. Alzheimers & Dementia
- Hepatic Autophagy Deficiency Compromises FXR Functionality and Causes Cholestatic Injury
- (2018) Bilon Khambu et al. HEPATOLOGY
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury
- (2018) Valentina Sepe et al. ACS Medicinal Chemistry Letters
- Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure
- (2018) Guoxiang Xie et al. EBioMedicine
- Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
- (2018) Hong Wang et al. EBioMedicine
- Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
- (2018) Jiyu Zhou et al. Acta Pharmaceutica Sinica B
- A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism
- (2017) Shujun Xie et al. FEBS LETTERS
- Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice
- (2017) Kang Ho Kim et al. HEPATOLOGY
- TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells
- (2017) Natalia Yanguas-Casás et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance
- (2017) Geoffrey A. Preidis et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of FXR pathway does not alter glial cell function
- (2017) Stefanie Albrecht et al. Journal of Neuroinflammation
- Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease
- (2017) David O. Rees et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
- (2017) Xiaoxin X. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
- (2017) Andi Marquardt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist
- (2017) Kyosuke Fujita et al. LIPIDS
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Targeting nuclear receptors for the treatment of fatty liver disease
- (2017) Naoki Tanaka et al. PHARMACOLOGY & THERAPEUTICS
- Unconjugated bile acids in rat brain: Analytical method based on LC/ESI-MS/MS with chemical derivatization and estimation of their origin by comparison to serum levels
- (2017) Tatsuya Higashi et al. STEROIDS
- Editor’s Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway
- (2017) Shogo Takahashi et al. TOXICOLOGICAL SCIENCES
- Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation
- (2017) Da-Gang Zhang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner
- (2017) Wenxuan Xu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice
- (2017) Matthew McMillin et al. Frontiers in Cellular Neuroscience
- Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System
- (2017) Kim L. Mertens et al. Frontiers in Neuroscience
- The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion
- (2016) Stephanie Hucke et al. ACTA NEUROPATHOLOGICA
- Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis
- (2016) Bo Kong et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
- (2016) Vittoria Massafra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- Effects of bile acids on neurological function and disease
- (2016) Matthew McMillin et al. FASEB JOURNAL
- Identification of functional farnesoid X receptors in brain neurons
- (2016) Chao Huang et al. FEBS LETTERS
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid
- (2016) Noortje Ijssennagger et al. JOURNAL OF HEPATOLOGY
- Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
- (2016) Runbin Sun et al. MOLECULAR PHARMACOLOGY
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
- (2016) Vivette D. D'Agati et al. Nature Reviews Nephrology
- Hepatic Encephalopathy
- (2016) Eelco F.M. Wijdicks NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis
- (2016) Peggy P. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming
- (2016) Yang Xie et al. Scientific Reports
- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors
- (2015) Cheryl A. Brighton et al. ENDOCRINOLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
- (2015) Chul-Su Yang et al. Nature Communications
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior
- (2015) Fei Huang et al. Frontiers in Behavioral Neuroscience
- Bile acid nuclear receptor FXR and digestive system diseases
- (2015) Lili Ding et al. Acta Pharmaceutica Sinica B
- Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
- (2015) Guodong Li et al. Acta Pharmaceutica Sinica B
- Role of farnesoid X receptor and bile acids in alcoholic liver disease
- (2015) Sharon Manley et al. Acta Pharmaceutica Sinica B
- A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
- (2014) D.-H. Kim et al. EMBO JOURNAL
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcriptional regulation of autophagy by an FXR–CREB axis
- (2014) Sunmi Seok et al. NATURE
- Nutrient-sensing nuclear receptors coordinate autophagy
- (2014) Jae Man Lee et al. NATURE
- Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
- (2014) Xiaoyan Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
- (2014) Sharon Manley et al. Redox Biology
- Endothelin-1 Overexpression Exacerbates Atherosclerosis and Induces Aortic Aneurysms in Apolipoprotein E Knockout Mice
- (2013) Melissa W. Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- (2013) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR)
- (2013) Wahiba Berrabah et al. HEPATOLOGY
- Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells
- (2013) Zhaosha Li et al. PHYSIOLOGICAL GENOMICS
- Bile Acids Activate YAP to Promote Liver Carcinogenesis
- (2013) Sayeepriyadarshini Anakk et al. Cell Reports
- Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma
- (2012) Hongying Su et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- FXR ligands protect against hepatocellular inflammation via SOCS3 induction
- (2012) Zhizhen Xu et al. CELLULAR SIGNALLING
- Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury
- (2012) Jun Pu et al. EUROPEAN HEART JOURNAL
- Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma
- (2012) Yuan Chen et al. HEPATOLOGY
- Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method
- (2012) Juan C. García-Cañaveras et al. JOURNAL OF LIPID RESEARCH
- Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion
- (2011) J Y Lee et al. BRITISH JOURNAL OF CANCER
- Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells
- (2011) J. Li et al. MOLECULAR PHARMACOLOGY
- The bile acid sensor FXR regulates insulin transcription and secretion
- (2010) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications
- (2010) Jongsook Kim Kemper BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Farnesoid X Receptor Activation Prevents the Development of Vascular Calcification in ApoE −/− Mice With Chronic Kidney Disease
- (2010) Shinobu Miyazaki-Anzai et al. CIRCULATION RESEARCH
- Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
- (2010) X. X. Wang et al. DIABETES
- Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis
- (2010) Tiangang Li et al. HEPATOLOGY
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- Activation of the Farnesoid X Receptor Provides Protection against Acetaminophen-Induced Hepatic Toxicity
- (2010) Florence Ying Lee et al. MOLECULAR ENDOCRINOLOGY
- Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
- (2010) J. R. Swann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
- (2009) Peter Fickert et al. AMERICAN JOURNAL OF PATHOLOGY
- Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages
- (2009) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
- (2009) B. Cariou DIABETES & METABOLISM
- The Bile Acid Sensor Farnesoid X Receptor Is a Modulator of Liver Immunity in a Rodent Model of Acute Hepatitis
- (2009) A. Mencarelli et al. JOURNAL OF IMMUNOLOGY
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Hepatic IL-17 responses in human and murine primary biliary cirrhosis
- (2008) Ruth Y.Z. Lan et al. JOURNAL OF AUTOIMMUNITY
- Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
- (2008) Hiroyuki Sato et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now